These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 12197451

  • 21. Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder.
    Koran LM, Aboujaoude E, Gamel NN.
    J Clin Psychiatry; 2009 Nov; 70(11):1530-5. PubMed ID: 19573497
    [Abstract] [Full Text] [Related]

  • 22. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.
    McElroy SL, Hudson JI, Malhotra S, Welge JA, Nelson EB, Keck PE.
    J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982
    [Abstract] [Full Text] [Related]

  • 23. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
    Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M.
    J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
    [Abstract] [Full Text] [Related]

  • 24. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo.
    Stein DJ, Andersen EW, Overo KF.
    Braz J Psychiatry; 2007 Dec; 29(4):303-7. PubMed ID: 18200396
    [Abstract] [Full Text] [Related]

  • 25. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
    Alaghband-Rad J, Hakimshooshtary M.
    Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
    Grant JE, Potenza MN.
    Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases.
    Thomsen PH.
    J Child Adolesc Psychopharmacol; 1997 Jul; 7(3):157-66. PubMed ID: 9466233
    [Abstract] [Full Text] [Related]

  • 34. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
    Montgomery SA, Nil R, Dürr-Pal N, Loft H, Boulenger JP.
    J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH.
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hoarding in obsessive-compulsive disorder: a report of 20 cases.
    Winsberg ME, Cassic KS, Koran LM.
    J Clin Psychiatry; 1999 Sep; 60(9):591-7. PubMed ID: 10520977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.